{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360574093618782848.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3390/cancers11070978"}},{"identifier":{"@type":"URI","@value":"https://www.mdpi.com/2072-6694/11/7/978/pdf"}}],"dc:title":[{"@value":"Are Integrins Still Practicable Targets for Anti-Cancer Therapy?"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Correlative clinical evidence and experimental observations indicate that integrin adhesion receptors, in particular those of the αV family, are relevant to cancer cell features, including proliferation, survival, migration, invasion, and metastasis. In addition, integrins promote events in the tumor microenvironment that are critical for tumor progression and metastasis, including tumor angiogenesis, matrix remodeling, and the recruitment of immune and inflammatory cells. In spite of compelling preclinical results demonstrating that the inhibition of integrin αVβ3/αVβ5 and α5β1 has therapeutic potential, clinical trials with integrin inhibitors targeting those integrins have repeatedly failed to demonstrate therapeutic benefits in cancer patients. Here, we review emerging integrin functions and their proposed contribution to tumor progression, discuss preclinical evidence of therapeutic significance, revisit clinical trial results, and consider alternative approaches for their therapeutic targeting in oncology, including targeting integrins in the other cells of the tumor microenvironment, e.g., cancer-associated fibroblasts and immune/inflammatory cells. We conclude that integrins remain a valid target for cancer therapy; however, agents with better pharmacological properties, alternative models for their preclinical evaluation, and innovative combination strategies for clinical testing (e.g., together with immuno-oncology agents) are needed.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380019302933110273","@type":"Researcher","foaf:name":[{"@value":"Begoña Alday-Parejo"}],"jpcoar:affiliationName":[{"@value":"Pathology Unit, Department of Oncology, Microbiology and Immunology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, Per 17, CH-1700 Fribourg, Switzerland"}]},{"@id":"https://cir.nii.ac.jp/crid/1380019302933110272","@type":"Researcher","foaf:name":[{"@value":"Roger Stupp"}],"jpcoar:affiliationName":[{"@value":"Departments of Neurological Surgery, Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Neurology and Medicine, Feinberg School of Medicine, Northwestern University, 676 N St Clair St, Suite 2210, Chicago, IL 60611, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1380019302933110274","@type":"Researcher","foaf:name":[{"@value":"Curzio Rüegg"}],"jpcoar:affiliationName":[{"@value":"Pathology Unit, Department of Oncology, Microbiology and Immunology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, Per 17, CH-1700 Fribourg, Switzerland"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"20726694"}],"prism:publicationName":[{"@value":"Cancers"}],"dc:publisher":[{"@value":"MDPI AG"}],"prism:publicationDate":"2019-07-12","prism:volume":"11","prism:number":"7","prism:startingPage":"978"},"reviewed":"false","dc:rights":["https://creativecommons.org/licenses/by/4.0/"],"url":[{"@id":"https://www.mdpi.com/2072-6694/11/7/978/pdf"}],"createdAt":"2019-07-12","modifiedAt":"2025-10-11","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360013168859626112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Influence of Linker Molecules in Hexavalent RGD Peptides on Their Multivalent Interactions with Integrin α<sub>v</sub>β<sub>3</sub>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757192707840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fucoxanthinol Promotes Apoptosis in MCF-7 and MDA-MB-231 Cells by Attenuating Laminins–Integrins Axis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568619123895552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579811541330048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Machine learning with imaging features to predict the expression of ITGAV, which is a poor prognostic factor derived from transcriptome analysis in pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360585256672050304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Isolation and Characterisation of Lymphatic Endothelial Cells from Lung Tissues Affected by Lymphangioleiomyomatosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567617031680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Integrin-Ligand Interactions in Inflammation, Cancer, and Metabolic Disease: Insights Into the Multifaceted Roles of an Emerging Ligand Irisin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593734537216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rac1‐mediated sustained β4 integrin level develops reattachment ability of breast cancer cells after anchorage loss"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861704778319488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Structure–Activity Relationships of RGD-Containing Peptides in Integrin αvβ5-Mediated Cell Adhesion"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861704783704960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3390/cancers11070978"},{"@type":"CROSSREF","@value":"10.1021/acs.jmedchem.1c01396_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.3390/onco2030010_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.3390/jcm9010090_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.3892/ijo.2022.5350_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.3389/fcell.2020.588066_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.1111/cas.14985_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-88064-3_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.1021/acsomega.2c06540_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0268630_references_DOI_YAR3ArlP9nsTkmOAitCcYmb7T7F"}]}